- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

First Batch of Russia’s Sputnik V Vaccine Arrives in Mexico

© REUTERS / AGUSTIN MARCARIANA shipment of doses of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19)
A shipment of doses of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19)  - Sputnik International, 1920, 23.02.2021
Subscribe
Mexico has become the first country in North America to approve Russia's Sputnik V vaccine against the coronavirus, the Russian Direct Investment Fund (RDIF), responsible for global production and distribution of the Sputnik V vaccine, said earier.

Mexico, the first North American counrty to approve Russia's Sputnik V vaccine under the emergency use authorisation procedure, received the first delivery of the jabs on Tuesday.

​Some 200,000 doses were delivered as part of the first batch. Russia is set to send 24 million jabs to get 12 million Mexicans inoculated.

A video of a plane loaded with the inoculations was shared by Mexican Foreign Minister Marcelo Ebrard C. on Twitter.

​The vaccination with Sputnik V in Mexico is set to start on 24 February.

The Federal Commission for the Protection against Sanitary Risk of Mexico (COFEPRIS) approved the Russian jab for emergency use without additional clinical trials in the country on 3 February. 

So far, a total of 30 countries have approved Sputnik V for use, making it among the top three most popular vaccines globally.

According to the Russian Direct Investment Fund (RDIF), Sputnik V had become "one of the world's top three coronavirus vaccines in terms of the number of approvals issued by government regulators".

A recent peer-reviewed study published in The Lancet journal stated that Sputnik V, which was developed by Russia's Gamaleya Research Centre of Epidemiology and Microbiology, showed 91.6 percent efficacy, based on Phase 3 clinical trial interim data. The vaccine, which is built on a human adenoviral vector platform, was registered by the Russian government on 11 August.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала